ME
GWPH

McIlrath & Eck’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

McIlrath & Eck’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-31
Closed -$7K – 848
2021
Q1 		$7K Buy
31
+16
+107% +$3.01K ﹤0.01% 551
2020
Q4 		$2K Hold
15
– – ﹤0.01% 641
2020
Q3 		$1K Hold
15
– – ﹤0.01% 660
2020
Q2 		$2K Hold
15
– – ﹤0.01% 616
2020
Q1 		$1K Hold
15
– – ﹤0.01% 653
2019
Q4 		$2K Hold
15
– – ﹤0.01% 586
2019
Q3 		$2K Buy
+15
New +$2.28K ﹤0.01% 575

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

McIlrath & Eck's GWPH Position: Q2 2021 in Review

McIlrath & Eck sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 31 shares — an estimated $7K sold.

McIlrath & Eck first reported a position in GWPH in Q3 2019 and held it in 7 quarters. The position peaked at $7K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • McIlrath & Eck reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • McIlrath & Eck sold 31 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $7K.
  • McIlrath & Eck first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2019 and held it in 7 quarters.
  • McIlrath & Eck's GW Pharmaceuticals Plc American Depositary Shares position peaked at $7K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on McIlrath & Eck's 13F filing for Q2 2021, filed 9 Aug 2021.